Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-10-31Clinical Trial Update: Treatment Landscape and Real-World Dosing Patterns With CDK4/6 Inhibitors for Breast Cancer in Portugal
A real-world analysis from Portugal examining usage patterns and dosing of CDK4/6 inhibitors for breast cancer.
-
CLINICAL_TRIALS research · 2025-10-31Clinical Trial Update: RAD 1802: Pilot Trial of Five Fraction Stereotactic Body Radiotherapy for Early Stage Breast Cancer Patients Eligible for Post-Operative Accelerated Partial Breast Irradiation (APBI) [NA]
Clinical trial update describing a pilot study of five-fraction stereotactic body radiotherapy for early-stage breast cancer patients eligib…
-
CLINICAL_TRIALS trial_result · 2025-10-31Clinical Trial Update: Breast Cancer Survivors Who Experience Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS)
A clinical trial evaluating aromatase inhibitor-associated musculoskeletal symptoms in breast cancer survivors has completed.
-
CLINICAL_TRIALS research · 2025-10-31Clinical Trial Update: TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer. (Sub-Study C) [Phase 1, Phase 2]
Clinical trial TACTIVE-U studies vepdegestrant in combination with other medicines for advanced or metastatic breast cancer (Sub-Study C). T…
-
CLINICAL_TRIALS research · 2025-10-31Clinical Trial Update: Lifting More Than Weights: Resistance Exercise Program Across Socioeconomic Groups for Cancer-Related Fatigue Management [NA]
This clinical trial update reports ongoing recruitment for a resistance exercise program to manage cancer-related fatigue in breast cancer p…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA approval · 2025-10-30EMA Authorised: Perjeta (pertuzumab) — Roche Registration GmbH
The EMA authorised Perjeta (pertuzumab) for breast cancer in the European Union, with the decision dated 04/09/2025.
-
CLINICAL_TRIALS research · 2025-10-30Clinical Trial Update: EMERALD: Endocrine Therapy oMission With Radiation in ER+ Breast Cancer: Assessing Quality of Life and Disease Control: a Prospective Phase II Trial [Phase 2]
A Phase II clinical trial (EMERALD) is evaluating endocrine therapy with radiation for ER-positive breast cancer to assess quality of life a…
-
CLINICAL_TRIALS research · 2025-10-30Clinical Trial Update: 177Lu-DOTATATE for the Treatment of Stage IV or Recurrent Breast Cancer [Phase 2]
Phase 2 clinical trial update for 177Lu-DOTATATE in Stage IV or recurrent breast cancer; the study is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-10-30Clinical Trial Update: (Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer [Phase 2]
A Phase 2 clinical trial update for Z-Endoxifen in premenopausal women with ER-positive, HER2-negative breast cancer, currently recruiting.
-
CLINICAL_TRIALS research · 2025-10-30Clinical Trial Update: Neoadjuvant Darolutamide Alone or in Combination With Standard Therapy for Stage II-IIIA, AR+, TNBC [Phase 2]
This Phase 2 neoadjuvant trial evaluates darolutamide alone or with standard therapy in AR-positive stage II-IIIA breast cancer, including t…
-
CLINICAL_TRIALS research · 2025-10-30Clinical Trial Update: Understanding and Predicting Breast Cancer Events After Treatment [NA]
This entry provides an update on an active_not_recruiting clinical trial investigating understanding and predicting breast cancer events aft…
-
CLINICAL_TRIALS research · 2025-10-30Clinical Trial Update: Abbreviated Breast MRI (AB-MRI) With Golden-angle Radial Compressed-sensing and Parallel Imaging (GRASP)
This clinical trial evaluates abbreviated breast MRI using golden-angle radial compressed-sensing and GRASP imaging for breast cancer and is…
-
CLINICAL_TRIALS trial_result · 2025-10-29Clinical Trial Update: Pilot Study of Bazedoxifene Plus Conjugated Estrogen on Imaging and Blood Biomarkers [EARLY_Phase 1]
Pilot phase 1 study evaluating the combination of bazedoxifene and conjugated estrogen on imaging and blood biomarkers in women at increased…
-
CLINICAL_TRIALS research · 2025-10-29Clinical Trial Update: Overdiagnosis and Breast Cancer Screening Decisions [NA]
A completed Yale University clinical trial update examining overdiagnosis and decision-making in breast cancer screening for older adults, i…
-
CLINICAL_TRIALS trial_result · 2025-10-29Clinical Trial Update: Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors [Phase 2]
A Phase 2 trial evaluating niraparib in patients with advanced PALB2-mutated tumors was terminated; results have been posted for multiple so…
-
CLINICAL_TRIALS research · 2025-10-29Clinical Trial Update: Ultra-hypofractionated Whole Breast Irradiation With Lumpectomy Cavity Boost for the Treatment of Stage I-III Breast Cancer [Phase 2]
A Phase 2 clinical trial evaluating ultra-hypofractionated whole breast irradiation with lumpectomy cavity boost for stage I-III breast canc…
-
CLINICAL_TRIALS research · 2025-10-29Clinical Trial Update: High Risk Breast Clinic: Protocol for Women at Increased Risk for Developing Breast Cancer
This document describes a clinical trial protocol (High Risk Breast Clinic) for women at increased risk of developing breast cancer and indi…
-
CLINICAL_TRIALS research · 2025-10-29Clinical Trial Update: Genetic Education in BRCA Families [NA]
A Georgetown University-sponsored clinical trial focused on genetic education in BRCA families is currently enrolling by invitation for part…
-
CLINICAL_TRIALS research · 2025-10-29Clinical Trial Update: Effects of Tirzepatide on Blood, Imaging and Breast Tissue Biomarkers
A clinical trial update examining how tirzepatide affects blood, imaging, and breast tissue biomarkers in the context of obesity and breast …
-
CLINICAL_TRIALS other · 2025-10-29Clinical Trial Update: VS-6766+Abema+Fulv in Met HR+/HER- BC [Phase 1, Phase 2]
Phase 1/Phase 2 trial evaluating VS-6766 in combination with Abemaciclib and Fulvestrant for metastatic hormone receptor-positive, HER2-nega…
-
CLINICAL_TRIALS research · 2025-10-29Clinical Trial Update: Phase IIB Trial of Bazedoxifene Plus Conjugated Estrogens [Phase 2]
An update on an active-not-recruiting Phase II trial evaluating the combination of bazedoxifene and conjugated estrogens for breast cancer r…
-
CLINICAL_TRIALS research · 2025-10-29Clinical Trial Update: Multiparametric MRI for Assessing Breast Cancer Response to Anti-HER2 Therapy
A clinical trial is evaluating multiparametric MRI as a noninvasive method to assess response of HER2-positive breast cancer to anti-HER2 th…
-
CLINICAL_TRIALS research · 2025-10-29Clinical Trial Update: T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer, the CompassHER2 RD Trial [Phase 3]
A Phase 3 clinical trial update comparing T-DM1 with tucatinib versus T-DM1 alone in preventing relapses in high-risk HER2-positive breast c…
-
EMA approval · 2025-10-28EMA Authorised: Phesgo (pertuzumab;trastuzumab) — Roche Registration GmbH
The European Medicines Agency has authorised Phesgo, a fixed-dose subcutaneous combination of pertuzumab and trastuzumab, for breast cancer …
-
CLINICAL_TRIALS research · 2025-10-28Clinical Trial Update: ABCSG 61 / TEODOR : Neoadjuvant TrEatment Optimization Driven by Circulating Tumor DNA and endOcrine Responsiveness [NA]
An ongoing neoadjuvant breast cancer trial (ABCSG 61/TEODOR) investigates treatment optimization guided by circulating tumor DNA and endocri…